ENVERIC BIOSCIENCES, INC. Proceeds from Common Stock Issued
ENVERIC BIOSCIENCES, INC. (ENVB) reported Proceeds from Common Stock Issued of $1.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-14
- ENVERIC BIOSCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2026-06-30 was -$7.38K.
- ENVERIC BIOSCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2026-03-31 was $1.30M.
- ENVERIC BIOSCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2024-12-31 was $0.00.
- ENVERIC BIOSCIENCES, INC. proceeds from issuance of common stock for the quarter ending 2024-09-30 was $0.00.
- ENVERIC BIOSCIENCES, INC. proceeds from issuance of common stock for fiscal 2024 was $2.29M.
- ENVERIC BIOSCIENCES, INC. proceeds from issuance of common stock for fiscal 2022 was $17.22M, a 20.32% decline from fiscal 2021.
- ENVERIC BIOSCIENCES, INC. proceeds from issuance of common stock for fiscal 2021 was $21.61M, a 4329.20% increase from fiscal 2020.
- ENVERIC BIOSCIENCES, INC. proceeds from issuance of common stock for fiscal 2020 was $488.00K, a 77.02% decline from fiscal 2019.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$7.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.29M 10-Q · filed 2026-08-14 | ||||
| 2026-03-31 | $1.30M 10-Q · filed 2026-05-15 | |||||
| 2025-06-30 | $578.50K 10-Q · filed 2026-08-14 | |||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | -$17.52K derived: sum of 3 quarters · filed 2026-03-27 | $2.29M 10-K · filed 2026-03-27 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$17.52K derived: sum of 2 quarters · filed 2025-11-14 | $2.29M 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | -$17.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $2.29M 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | $2.31M 10-Q · filed 2025-05-14 | |||||
| 2022-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $7.82M derived: sum of 2 quarters · filed 2024-03-26 | $7.82M derived: sum of 3 quarters · filed 2024-03-26 | $17.22M 10-K · filed 2024-03-26 | ||
| 2022-09-30 | $7.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $7.82M derived: sum of 2 quarters · filed 2022-11-14 | $17.22M 10-Q · filed 2022-11-14 | $17.22M derived: sum of 4 quarters · filed 2023-06-09 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $9.40M 10-Q · filed 2022-08-12 | $9.40M derived: sum of 3 quarters · filed 2023-06-09 | $9.40M derived: sum of 4 quarters · filed 2023-06-09 | ||
| 2022-03-31 | $9.40M 10-Q · filed 2022-05-13 | $9.40M derived: sum of 2 quarters · filed 2023-06-09 | $9.40M derived: sum of 3 quarters · filed 2023-06-09 | $9.40M derived: sum of 4 quarters · filed 2023-06-09 | ||
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-09 | $0.00 derived: sum of 2 quarters · filed 2023-06-09 | $0.00 derived: sum of 3 quarters · filed 2023-06-09 | $21.61M 10-K/A · filed 2023-06-09 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $21.61M 10-Q · filed 2022-11-14 | $21.87M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $21.61M 10-Q · filed 2022-08-12 | $21.87M derived: sum of 3 quarters · filed 2022-08-12 | $20.38M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | $21.61M 10-Q · filed 2022-05-13 | $21.87M derived: sum of 2 quarters · filed 2022-05-13 | $20.38M derived: sum of 3 quarters · filed 2022-05-13 | $22.10M derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $260.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$1.24M derived: sum of 2 quarters · filed 2022-03-31 | $488.00K derived: sum of 3 quarters · filed 2022-03-31 | $488.00K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | -$1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $227.50K derived: sum of 2 quarters · filed 2021-11-15 | $227.50K 10-Q · filed 2021-11-15 | $1.73M 10-Q · filed 2020-11-16 | $227.67K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $1.73M 10-Q · filed 2020-08-14 | $1.73M derived: sum of 3 quarters · filed 2020-08-14 | $1.73M derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 | $169.00 derived: sum of 2 quarters · filed 2020-08-12 | $169.00 derived: sum of 3 quarters · filed 2020-11-16 | $656.00K derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-12-31 | $169.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-12 | $169.00 derived: sum of 2 quarters · filed 2020-11-16 | $656.00K derived: sum of 3 quarters · filed 2020-11-16 | $2.12M 10-K/A · filed 2020-08-12 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $655.83K derived: sum of 2 quarters · filed 2020-11-16 | $2.12M 10-Q · filed 2020-11-16 | $2.12M 10-Q · filed 2019-11-08 | $2.14M derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | $655.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $2.12M 10-Q · filed 2020-08-14 | $2.14M derived: sum of 3 quarters · filed 2020-08-14 | $7.82M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $1.47M 10-Q · filed 2020-05-15 | $1.49M derived: sum of 2 quarters · filed 2020-08-12 | $7.17M derived: sum of 3 quarters · filed 2020-08-12 | $7.18M derived: sum of 4 quarters · filed 2020-08-12 | ||
| 2018-12-31 | $19.33K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-12 | $5.70M derived: sum of 2 quarters · filed 2020-08-12 | $5.71M derived: sum of 3 quarters · filed 2020-08-12 | $6.33M 10-K/A · filed 2020-08-12 | ||
| 2018-09-30 | $5.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $5.69M derived: sum of 2 quarters · filed 2019-11-08 | $6.31M 10-Q · filed 2019-11-08 | $11.21M derived: sum of 4 quarters · filed 2019-11-08 | ||
| 2018-06-30 | $9.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $628.28K 10-Q · filed 2019-08-14 | $5.53M derived: sum of 3 quarters · filed 2019-08-14 | $5.53M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $619.03K 10-Q · filed 2019-05-14 | $5.52M derived: sum of 2 quarters · filed 2019-05-14 | $5.52M derived: sum of 3 quarters · filed 2019-05-14 | $5.52M derived: sum of 4 quarters · filed 2019-05-14 | ||
| 2017-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $4.90M derived: sum of 2 quarters · filed 2019-03-26 | $4.90M derived: sum of 3 quarters · filed 2019-03-26 | $4.90M 10-K · filed 2019-03-26 | ||
| 2017-11-21 | $6.08M 10-K · filed 2018-04-02 | |||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | $0.00 derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | $0.00 derived: sum of 3 quarters · filed 2018-08-14 | $0.00 derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-15 | $0.00 derived: sum of 2 quarters · filed 2018-05-15 | $0.00 derived: sum of 3 quarters · filed 2018-05-15 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $5.00M 10-K · filed 2018-04-02 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $5.00M 10-Q · filed 2017-11-13 | ||||
| 2016-06-30 | $5.00M 10-Q · filed 2017-08-14 | |||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $0.00 derived: sum of 2 quarters · filed 2015-03-31 | $0.00 derived: sum of 3 quarters · filed 2015-03-31 | $50.00K 10-K · filed 2015-03-31 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $0.00 derived: sum of 2 quarters · filed 2014-11-14 | $50.00K 10-Q · filed 2014-11-14 | $150.00K derived: sum of 4 quarters · filed 2015-05-14 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $50.00K 10-Q · filed 2014-08-11 | $150.00K derived: sum of 3 quarters · filed 2015-05-14 | $150.00K derived: sum of 4 quarters · filed 2015-05-14 | ||
| 2014-03-31 | $50.00K 10-Q · filed 2015-05-14 | $150.00K derived: sum of 2 quarters · filed 2015-05-14 | $150.00K derived: sum of 3 quarters · filed 2015-05-14 | |||
| 2013-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $100.00K derived: sum of 2 quarters · filed 2015-03-31 | $100.00K 10-K · filed 2015-03-31 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $0.00 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-11 | |||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $20.00K 10-K · filed 2013-02-28 | ||||
| 2011-09-30 | $20.00K 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |